Iterum Therapeutics plc ( ITRM) - Key Metrics
Stock symbol ITRM is outdated, potentially delisted? Maybe it is available on other exchange?
ITRM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | $0.01 | -$0.20 | -$0.17 | -$0.17 |
| 2025Q2 | ? | -$0.16 | -$0.12 | -$0.12 |
| 2025Q1 | ? | -$0.14 | -$0.09 | -$0.09 |
| 2024Q4 | ? | -$0.33 | -$0.22 | -$0.22 |
| 2024Q3 | ? | -$0.30 | -$0.13 | -$0.13 |
ITRM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | ? | -0.85 |
| 2025Q2 | ? | -1.53 |
| 2025Q1 | ? | -2.14 |
| 2024Q4 | ? | -1.32 |
| 2024Q3 | ? | -0.90 |
ITRM
Price: $0.03
52 week price:
Earnings Per Share: -0.72 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Ireland
Volume: 35952
Market Capitalization: 1.6 million